CA2724322C - Diagnosis of melanoma and solar lentigo by nucleic acid analysis - Google Patents

Diagnosis of melanoma and solar lentigo by nucleic acid analysis Download PDF

Info

Publication number
CA2724322C
CA2724322C CA2724322A CA2724322A CA2724322C CA 2724322 C CA2724322 C CA 2724322C CA 2724322 A CA2724322 A CA 2724322A CA 2724322 A CA2724322 A CA 2724322A CA 2724322 C CA2724322 C CA 2724322C
Authority
CA
Canada
Prior art keywords
melanoma
skin
nucleic acid
protein
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2724322A
Other languages
English (en)
French (fr)
Other versions
CA2724322A1 (en
Inventor
Sherman H. Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermtech Inc
Original Assignee
Dermtech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermtech Inc filed Critical Dermtech Inc
Publication of CA2724322A1 publication Critical patent/CA2724322A1/en
Application granted granted Critical
Publication of CA2724322C publication Critical patent/CA2724322C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/60In silico combinatorial chemistry
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Computing Systems (AREA)
  • Library & Information Science (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2724322A 2008-05-14 2009-05-14 Diagnosis of melanoma and solar lentigo by nucleic acid analysis Active CA2724322C (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US12773108P 2008-05-14 2008-05-14
US61/127,731 2008-05-14
US5398808P 2008-05-16 2008-05-16
US61/053,988 2008-05-16
US5814908P 2008-06-02 2008-06-02
US61/058,149 2008-06-02
PCT/US2009/044035 WO2009140550A2 (en) 2008-05-14 2009-05-14 Diagnosis of melanoma and solar lentigo by nucleic acid analysis

Publications (2)

Publication Number Publication Date
CA2724322A1 CA2724322A1 (en) 2009-11-19
CA2724322C true CA2724322C (en) 2019-07-16

Family

ID=41319348

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2724322A Active CA2724322C (en) 2008-05-14 2009-05-14 Diagnosis of melanoma and solar lentigo by nucleic acid analysis

Country Status (8)

Country Link
US (8) US20110160080A1 (enExample)
EP (2) EP2626437A3 (enExample)
JP (1) JP2011520451A (enExample)
CN (1) CN102089444A (enExample)
AU (1) AU2009246180B2 (enExample)
BR (1) BRPI0913578A2 (enExample)
CA (1) CA2724322C (enExample)
WO (1) WO2009140550A2 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2311981B1 (en) 2007-05-01 2014-09-17 The Regents of The University of California Methods for diagnosing ischemia
WO2008137772A1 (en) * 2007-05-04 2008-11-13 Dermtech International Diagnosis of melanoma by nucleic acid analysis
BRPI0913578A2 (pt) 2008-05-14 2017-06-06 Dermtech Int diagnose de melanoma e lentigo solar por análise de ácido nucléico
EP2593566B1 (en) 2010-07-14 2018-01-24 The Regents of The University of California Biomarkers for diagnosis of transient ischemic attacks
CA2804802C (en) 2010-07-15 2023-03-07 The Regents Of The University Of California Biomarkers for diagnosis of stroke and its causes
US20120316076A1 (en) 2011-03-04 2012-12-13 The Regents Of The University Of California Biomarkers for the diagnosis of lacunar stroke
WO2012135651A1 (en) 2011-03-31 2012-10-04 The Procter & Gamble Company Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis
FR2974373B1 (fr) * 2011-04-22 2016-09-02 Oreal Signature moleculaire des taches pigmentaires cutanees, associee a la matrice extracellulaire
FR2974370B1 (fr) * 2011-04-22 2016-09-02 Oreal Signature moleculaire des taches pigmentaires cutanees, associee a la voie de signalisation tgf-beta - smad
CN103619318B (zh) * 2011-04-22 2018-06-05 欧莱雅 和细胞外基质相关的皮肤色斑分子标签
CN103619317B (zh) * 2011-04-22 2017-06-09 欧莱雅 和细胞外基质结构相关的皮肤色斑分子标签
FR2974372B1 (fr) * 2011-04-22 2016-09-02 Oreal Signature moleculaire des taches pigmentaires cutanees, associee au remodelage de la matrice extracellulaire
FR2974371B1 (fr) * 2011-04-22 2016-10-28 Oreal Signature moleculaire des taches pigmentaires cutanees, associee a la famille des proteoglycanes et glycoproteines extracellulaires
WO2013103781A1 (en) 2012-01-07 2013-07-11 The Regents Of The University Of California Biomarkers for diagnosing ischemia
US10418127B2 (en) * 2012-03-30 2019-09-17 The Procter & Gamble Company Method of formulating a skin-lightening composition
JP2015527630A (ja) 2012-06-06 2015-09-17 ザ プロクター アンド ギャンブルカンパニー ヘア/頭皮ケア組成物向け化粧剤の同定システム及び方法
US9758829B2 (en) 2012-06-22 2017-09-12 Htg Molecular Diagnostics, Inc. Molecular malignancy in melanocytic lesions
KR102017562B1 (ko) * 2013-03-13 2019-09-03 (주)아모레퍼시픽 미백 효능 물질의 스크리닝 방법
ES2824248T3 (es) 2013-03-15 2021-05-11 Myriad Genetics Inc Genes y genes distintivos para el diagnóstico y tratamiento de melanoma
US20150005184A1 (en) * 2013-06-28 2015-01-01 Dermtech International Diagnosis of melanoma by nucleic acid analysis
FR3015523B1 (fr) * 2013-12-20 2020-05-29 L'oreal Signature moleculaire du lentigo actinique
FR3015525B1 (fr) * 2013-12-20 2017-06-09 Oreal Biomarqueur rnase 7 du lentigo actinique
FR3015524B1 (fr) * 2013-12-20 2016-06-03 Oreal Signature moleculaire du lentigo actinique specifique des peaux asiatiques
FR3015526B1 (fr) * 2013-12-20 2017-02-17 Oreal Biomarqueur npy1r du lentigo actinique
ES2946681T3 (es) 2014-07-02 2023-07-24 Myriad Mypath Llc Genes y firmas génicas para el diagnóstico y tratamiento del melanoma
WO2016152352A1 (ja) * 2015-03-20 2016-09-29 国立大学法人名古屋大学 メラノーマ特異的バイオマーカー及びその利用
US10709428B2 (en) 2015-05-01 2020-07-14 Dermtech, Inc. Non-invasive skin collection system
EP3433615A1 (en) * 2016-03-21 2019-01-30 Institut National de la Sante et de la Recherche Medicale (INSERM) Methods for diagnosis and treatment of solar lentigo
EP3719138B1 (en) 2016-07-08 2022-09-21 Kao Corporation Method for preparing nucleic acid sample
US11976332B2 (en) 2018-02-14 2024-05-07 Dermtech, Inc. Gene classifiers and uses thereof in non-melanoma skin cancers
CA3099275A1 (en) 2018-05-09 2019-11-14 Dermtech, Inc. Novel gene classifiers and uses thereof in autoimmune diseases
AU2020247911A1 (en) 2019-03-26 2021-11-11 Dermtech, Llc Novel gene classifiers and uses thereof in skin cancers
MX2021012206A (es) * 2019-04-05 2021-12-10 Dermtech Inc Clasificadores de genes novedosos para su uso en el monitoreo de daño ultravioleta.
EP3883149A1 (en) * 2020-03-20 2021-09-22 Volkswagen Ag Method, apparatus and computer program for predicting a future quality of service of a wireless communication link
US20230304091A1 (en) * 2020-08-10 2023-09-28 Cutis Biomedical Research Center Minimally invasive kit for diagnosing skin condition, comprising microneedle patch
WO2022115487A1 (en) * 2020-11-24 2022-06-02 Dermtech, Inc. Assessment of mutation burden in skin
USD988399S1 (en) 2021-02-16 2023-06-06 Dermtech, Inc. Dermatology report document
USD989861S1 (en) 2021-02-16 2023-06-20 Dermtech, Inc. Dermatology report document
USD966299S1 (en) 2021-02-16 2022-10-11 Dermtech, Inc. Computer display panel with a graphical user interface for a dermatology report
USD966300S1 (en) 2021-02-16 2022-10-11 Dermtech, Inc. Computer display panel with a graphical user interface for a dermatology report
US20240191309A1 (en) * 2021-04-13 2024-06-13 Dermtech, Inc. Gene classifiers and uses thereof
WO2023015286A1 (en) * 2021-08-05 2023-02-09 The Regents Of The University Of California Gene/protein expression guided melanoma surgery
FR3135992A1 (fr) * 2022-05-25 2023-12-01 L'oreal Signature moléculaire du lentigo actinique associée à la gestion des vésicules
USD1061554S1 (en) 2022-09-09 2025-02-11 Dermtech, Llc Computer display panel with a graphical user interface for a dermatology report
GB202302959D0 (en) 2023-02-28 2023-04-12 Mitra Bio Ltd A method for determining a stage of an epigenetic property of an epidermis
WO2024192031A1 (en) * 2023-03-12 2024-09-19 Novelna Inc. Melanoma detection proteins and methods of use thereof

Family Cites Families (254)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441430A (en) 1964-11-19 1969-04-29 Minnesota Mining & Mfg Adhesives and adhesive tapes
US4122947A (en) 1978-01-27 1978-10-31 Falla Marjorie B Pre-packaged patient identification kit
JPS567007A (en) 1979-06-29 1981-01-24 Toshiba Corp Coating film thickness measuring apparatus
GB2061598B (en) 1979-10-15 1983-03-02 Chloride Silent Power Ltd Filling sodium-sulphur cells
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
JPS57156456A (en) 1981-03-24 1982-09-27 Shizuoka Daigaku Preparation of 1,5,5-trimethyl-3-amino-4-cyanocyclohexa-1,3- diene and its derivative
US4388432A (en) 1981-12-15 1983-06-14 Permacel Repulpable acrylic acid based pressure-sensitive adhesive
US4537776A (en) 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
SE443914B (sv) 1984-10-01 1986-03-17 Torkel Ingemar Fischer Medel for en overkenslighetstest
US4851510A (en) 1984-11-30 1989-07-25 Wadley Technologies, Inc. Monoclonal antibodies to novel melanoma-associated antigens
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4777964A (en) 1986-01-02 1988-10-18 David Briggs System for obtaining blood samples and submitting for testing of aids
US5460939A (en) 1986-04-18 1995-10-24 Advanced Tissue Sciences, Inc. Temporary living skin replacement
US4971800A (en) 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
US5493009A (en) 1989-11-14 1996-02-20 New York Medical College Antiidiotypic monoclonal antibodies MK2-23 anti-melanomal antibody 763.74
DE69121791T2 (de) 1990-06-08 1997-01-23 Behringwerke Ag Verfahren zur quantitativen Bestimmung von DNS-Sequenzen
US6033854A (en) 1991-12-16 2000-03-07 Biotronics Corporation Quantitative PCR using blocking oligonucleotides
US5583032A (en) 1992-10-21 1996-12-10 The Cleveland Clinic Foundation And National Institutes Of Health Method of cleaving specific strands of RNA
US5753612A (en) 1992-10-27 1998-05-19 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
US5654286A (en) 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
AU7324994A (en) 1993-07-08 1995-02-06 Avery Dennison Corporation Acrylic-saturated rubber hybrid pressure-sensitive adhesives
WO1995006137A1 (en) 1993-08-27 1995-03-02 Australian Red Cross Society Detection of genes
US5843657A (en) 1994-03-01 1998-12-01 The United States Of America As Represented By The Department Of Health And Human Services Isolation of cellular material under microscopic visualization
US5989815A (en) 1994-03-18 1999-11-23 University Of Utah Research Foundation Methods for detecting predisposition to cancer at the MTS gene
US5962477A (en) 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US7625697B2 (en) 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
JPH0852142A (ja) 1994-07-01 1996-02-27 Medical Biopsy Inc 試料保持手段を備えた生検針組立体及びその使用方法
IT1278052B1 (it) 1995-03-14 1997-11-17 Mendes Srl Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per
US5750341A (en) 1995-04-17 1998-05-12 Lynx Therapeutics, Inc. DNA sequencing by parallel oligonucleotide extensions
US6852487B1 (en) 1996-02-09 2005-02-08 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
US6054277A (en) 1996-05-08 2000-04-25 Regents Of The University Of Minnesota Integrated microchip genetic testing system
US5811239A (en) 1996-05-13 1998-09-22 Frayne Consultants Method for single base-pair DNA sequence variation detection
CA2255774C (en) 1996-05-29 2008-03-18 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US5858683A (en) 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
US5921396A (en) 1997-01-21 1999-07-13 Brown, Jr.; Jacob T. Specimen collection kit for mailing and method of using same
US6056859A (en) 1997-02-12 2000-05-02 Lockheed Martin Energy Research Corporation Method and apparatus for staining immobilized nucleic acids
DE19733014A1 (de) 1997-07-31 1999-02-04 Beiersdorf Ag Selbstklebeband
US6551799B2 (en) 1999-12-07 2003-04-22 Genentech, Inc. Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
US20020006913A1 (en) 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
US6054276A (en) 1998-02-23 2000-04-25 Macevicz; Stephen C. DNA restriction site mapping
US6106732A (en) 1998-04-16 2000-08-22 Binax Services, Inc. Integral blood plasma or serum isolation, metering and transport device
US6891022B1 (en) 1998-04-23 2005-05-10 Genentech, Inc. NSP molecules
CA2330673C (en) 1998-05-01 2009-05-26 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and dna molecules
US6780591B2 (en) 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US6787308B2 (en) 1998-07-30 2004-09-07 Solexa Ltd. Arrayed biomolecules and their use in sequencing
ATE491462T1 (de) 1998-08-18 2011-01-15 Dermtech Int Methode zum nachweis biologischer faktoren in der epidermis
KR100326937B1 (ko) 1998-09-23 2002-03-13 정연보 접착성 쉬트로 사람의 표피 dna 샘플을 획득하는 방법
US6176836B1 (en) 1998-09-25 2001-01-23 David Trudil Biological sample collection kit
US6203987B1 (en) 1998-10-27 2001-03-20 Rosetta Inpharmatics, Inc. Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns
US7700324B1 (en) 1998-11-03 2010-04-20 The Johns Hopkins University School Of Medicine Methylated CpG island amplification (MCA)
WO2000040749A2 (en) 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
US7094533B1 (en) 1999-01-21 2006-08-22 Board Of Regents Of The University Of Nebraska Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer
US6274362B1 (en) 1999-02-04 2001-08-14 Millennium Pharmaceuticals, Inc. RGS-containing molecules and uses thereof
US6982089B2 (en) 1999-02-24 2006-01-03 Tact Ip, Llc Cytokine antagonists for neurological and neuropsychiatric disorders
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6180349B1 (en) 1999-05-18 2001-01-30 The Regents Of The University Of California Quantitative PCR method to enumerate DNA copy number
US6569624B1 (en) 1999-08-12 2003-05-27 Wisconsin Alumni Research Foundation Identification of genetic markers of biological age and metabolism
AUPQ265899A0 (en) 1999-09-03 1999-09-30 Genetic Solutions Pty Ltd Sampling system
AU7987800A (en) 1999-09-29 2001-04-30 Lifespan Biosciences, Inc. Anti-aging nucleic acid and protein targets
US6447463B1 (en) 1999-11-10 2002-09-10 Piotr Borkowski Highly sensitive, practical, widely available diagnostic kit for fungal skin infections
US6726971B1 (en) 1999-12-13 2004-04-27 Tyco Adhesives Lp Thermally stable clear polyurethane adhesive tape
IL133976A (en) 2000-01-11 2006-09-05 Dermipsor Ltd Agents for the treatment of skin disorders
US7611869B2 (en) 2000-02-07 2009-11-03 Illumina, Inc. Multiplexed methylation detection methods
JP2001228449A (ja) * 2000-02-14 2001-08-24 Hamamatsu Photonics Kk レーザ集光装置及びレーザ加工装置
JP2005520479A (ja) 2000-05-09 2005-07-14 ジェネティクス インスティテュート,エルエルシー 乾癬の確認、評価、予防および治療のための組成物、キットおよび方法
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
US7105292B2 (en) 2000-09-08 2006-09-12 New York University Screening methods used to identify compounds that modulate a response of a cell to ultraviolet radiation exposure
US20020165192A1 (en) 2000-09-19 2002-11-07 Kerr William G. Control of NK cell function and survival by modulation of ship activity
US20030017573A1 (en) * 2000-10-04 2003-01-23 Board Of Regents, The University Of Texas System Polymerase kappa compositions and methods thereof
DE10100121A1 (de) 2001-01-03 2002-08-01 Henkel Kgaa Verfahren zur Bestimmung des Hautstreß oder der Hautalterung in vitro
US20020132274A1 (en) 2001-01-17 2002-09-19 Nevalainen Marja T. Diagnostic and monitorings methods for cancer
WO2002098370A2 (en) 2001-03-02 2002-12-12 Medimmune, Inc. Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
US6642298B2 (en) 2001-03-16 2003-11-04 National Starch And Chemical Investment Holding Corporation Rubber-acrylic adhesive formulation
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
DE10130800B4 (de) 2001-06-22 2005-06-23 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierung mit hoher Sensitivität
US7297480B2 (en) 2001-06-28 2007-11-20 Dermtech International Method for detection of melanoma
US6749792B2 (en) 2001-07-09 2004-06-15 Lifescan, Inc. Micro-needles and methods of manufacture and use thereof
JP2003029201A (ja) 2001-07-11 2003-01-29 Canon Inc 画像投射装置及び画像補正方法
US20030133936A1 (en) 2001-07-12 2003-07-17 Byrne Michael Chapman CD25markers and uses thereof
US7229774B2 (en) * 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
US7247426B2 (en) * 2001-08-02 2007-07-24 Agilent Technologies, Inc. Classifying cancers
US6857262B2 (en) 2001-08-16 2005-02-22 Spx Corporation Catalytic converter function detection
WO2003032259A1 (en) * 2001-09-27 2003-04-17 Fujitsu Limited Efficient download of content data through network
CN102402650A (zh) 2001-11-09 2012-04-04 生命技术公司 利用基因表达分布图识别、监控和治疗疾病以及鉴定生物学状态
US6692032B2 (en) * 2001-11-28 2004-02-17 Melanie Ann Christy Mole monitoring system
US20030113906A1 (en) 2001-12-14 2003-06-19 Sangha Jangbir S. Method and apparatus for DNA collection
US7921999B1 (en) 2001-12-20 2011-04-12 Watson Laboratories, Inc. Peelable pouch for transdermal patch and method for packaging
US20090082265A1 (en) 2002-01-04 2009-03-26 Myriad Genetics, Incorporated Compositions and methods for treating diseases
US7396871B2 (en) 2002-01-14 2008-07-08 Eastman Chemical Comapny Rubber modified acrylic and/or vinyl hybrid resins
AU2003212878A1 (en) 2002-01-30 2003-09-02 Epigenomics Ag Identification of cell differentiation states based on methylation patterns
US20030167556A1 (en) 2002-03-05 2003-09-11 Consumers Choice Systems, Inc. Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging
US20030224422A1 (en) 2002-04-08 2003-12-04 St. Jude Children's Research Hospital, Inc. Pre-and post therapy gene expression profiling to identify drug targets
EP1511690A4 (en) 2002-05-16 2007-10-24 Univ Vanderbilt METHOD FOR PREDICTING AUTOIMMUNE DISEASES
US7217853B2 (en) 2002-05-24 2007-05-15 Corium International, Inc. Composition for cushions, wound dressings and other skin-contacting products
US7267951B2 (en) 2002-06-05 2007-09-11 Sloan-Kettering Institute For Cancer Research Method for evaluating a tissue or biopsy sample to determine if the sample is early-stage melanoma
JP4384603B2 (ja) 2002-06-26 2009-12-16 コールド スプリング ハーバー ラボラトリー メチル化プロファイルを測定するための方法および組成物
US20080260744A1 (en) 2002-09-09 2008-10-23 Omeros Corporation G protein coupled receptors and uses thereof
WO2004024077A2 (en) 2002-09-11 2004-03-25 Genentech, Inc. Novel composition and methods for the treatment of psoriasis
US20070077553A1 (en) 2003-10-30 2007-04-05 Rosetta Genomics Bioinformatically detectable group of novel vaccinia regulatory genes and uses thereof
JP2011516026A (ja) 2002-11-26 2011-05-26 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための組成物と方法
US20040191782A1 (en) 2003-03-31 2004-09-30 Yixin Wang Colorectal cancer prognostics
WO2004105573A2 (en) 2003-05-21 2004-12-09 The Wistar Institute Of Anatomy And Biology Method of diagnosis of cancer based on gene expression profiles in cells
CA2528669A1 (en) 2003-06-09 2005-01-20 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
EP2107129B1 (en) 2003-07-31 2012-08-22 Sequenom, Inc. Methods for high level multiplexed polymerase chain reactions and homogeneous mass extension reactions for genotyping of polymorhisms
EP1510577A1 (en) 2003-08-29 2005-03-02 Qiagen GmbH Method for magnetic bead isolation of nucleic acids
IL157786A (en) 2003-09-07 2010-11-30 Ahava Dead Sea Lab Ltd Personalized cosmetics
US9217694B2 (en) 2003-10-21 2015-12-22 Leica Microsystems Cms Gmbh Method for automatically generating laser cutting lines in laser microdissection processes
ATE553218T1 (de) 2003-10-21 2012-04-15 Orion Genomics Llc Differentielle enzymatische fragmetierung
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
EP1557449A1 (en) 2004-01-22 2005-07-27 3M Innovative Properties Company Adhesive tape for structural bonding
US20050261210A1 (en) 2004-02-19 2005-11-24 Bhatnagar Rajiv S Nonsense suppressor agents in treatment of cutaneous and gastrointestinal disorders
US20050202479A1 (en) 2004-02-27 2005-09-15 Nuvelo, Inc. Methods and materials relating to insulin growth factor-like (IGFL) polypeptides and polynucleotides
WO2005085477A1 (en) 2004-03-02 2005-09-15 Orion Genomics Llc Differential enzymatic fragmentation by whole genome amplification
JP4526839B2 (ja) 2004-03-05 2010-08-18 株式会社資生堂 角層中の酸化タンパク質を指標とする角層の透明性・保水性を評価する方法
US7183057B2 (en) 2004-03-31 2007-02-27 Dermtech International Tape stripping methods for analysis of skin disease and pathological skin state
US20050287593A1 (en) 2004-05-03 2005-12-29 Schering Corporation Use of cytokine expression to predict skin inflammation; methods of treatment
AU2005241020B2 (en) 2004-05-03 2008-07-10 Merck Sharp & Dohme Corp. Use of IL-17 expression to predict skin inflammation; methods of treatment
JP4790231B2 (ja) 2004-06-17 2011-10-12 花王株式会社 表皮の解析方法
AU2005258000B2 (en) * 2004-06-21 2011-02-03 Progenra Inc. Diagnostic and screening methods and kits associated with proteolytic activity
PT1812590E (pt) * 2004-06-25 2009-07-06 Veridex Llc Métodos e reagentes para a detecção de melanoma
US20070154889A1 (en) * 2004-06-25 2007-07-05 Veridex, Llc Methods and reagents for the detection of melanoma
US7635563B2 (en) 2004-06-30 2009-12-22 Massachusetts Institute Of Technology High throughput methods relating to microRNA expression analysis
CA2574447A1 (en) 2004-07-15 2006-01-26 University Of Utah Research Foundation Housekeeping genes and methods for identifying the same
WO2006039399A2 (en) * 2004-09-29 2006-04-13 University Of Rochester Staufen 1 (stau1) - mediated mrna decay
WO2006043362A1 (ja) 2004-10-19 2006-04-27 Kumamoto University 悪性黒色腫(メラノーマ)の新規な診断キット
US7643818B2 (en) 2004-11-22 2010-01-05 Seven Networks, Inc. E-mail messaging to/from a mobile terminal
WO2006056480A2 (en) 2004-11-29 2006-06-01 Klinikum Der Universität Regensburg Means and methods for detecting methylated dna
JP5059600B2 (ja) 2005-03-18 2012-10-24 株式会社 資生堂 扁平上皮細胞癌関連抗原を指標とする皮膚性状の評価方法
WO2006110594A2 (en) * 2005-04-07 2006-10-19 Novartis Vaccines And Diagnostics Inc. Sema4d in cancer diagnosis, detection and treatment
US20090203639A1 (en) 2005-04-15 2009-08-13 Oncomethylome Sciences, Inc. Methylation Markers for Diagnoses and Treatment of Cancers
JP2008545418A (ja) 2005-05-27 2008-12-18 ジョン ウェイン キャンサー インスティチュート 癌の診断、予後診断、および治療のための遊離循環dnaの使用
US20070082347A1 (en) 2005-06-08 2007-04-12 Myriad Genetics, Incorporated Gene variants and use thereof
US20070099209A1 (en) 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
JP2007050126A (ja) 2005-08-18 2007-03-01 Dr Ito Procare Cosmetics:Kk 美容方法
US7972788B2 (en) 2005-08-23 2011-07-05 Fancl Corporation Skin aging marker and technique for use thereof
US7608395B2 (en) 2005-09-15 2009-10-27 Baylor Research Institute Systemic lupus erythematosus diagnostic assay
US20070243537A1 (en) 2006-04-14 2007-10-18 Tuck Edward F Human sample matching system
CN101292032A (zh) 2005-10-21 2008-10-22 株式会社芳珂 特应性皮炎标记物及其利用技术
CA2630974A1 (en) 2005-11-23 2007-05-31 University Of Utah Research Foundation Methods and compositions involving intrinsic genes
EP1971868A2 (en) 2006-01-05 2008-09-24 Galderma Research & Development, S.N.C. Acne lesions biomarkers and modulators thereof
JP5027528B2 (ja) 2006-03-02 2012-09-19 株式会社ファンケル 皮膚老化の検査方法
WO2007124072A2 (en) 2006-04-20 2007-11-01 Dermtech International Methods for capture and detection of micro-rna molecules from the skin by non-invasive tape stripping
AU2007244868B2 (en) 2006-04-24 2013-11-21 Genentech, Inc. Methods and compositions for detecting autoimmune disorders
CN101472611A (zh) 2006-06-19 2009-07-01 惠氏公司 调节il-22和il-17的方法
US20090317840A1 (en) 2006-07-27 2009-12-24 Heinrichs Jon H Automated determination of chlamydia infection-forming units
PT2062049E (pt) 2006-09-06 2014-07-28 Univ California Diagnóstico molecular e classificação de melanoma maligno
US7615349B2 (en) 2006-09-07 2009-11-10 H. Lee Moffitt Cancer Center And Research Institute, Inc. Melanoma gene signature
WO2008036238A2 (en) 2006-09-19 2008-03-27 Wyeth Use of lxr modulators for the prevention and treatment of skin aging
EP2069377A4 (en) 2006-09-27 2009-11-11 Univ California METHOD AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND SKIN FUNCTIONAL DISORDERS
US8148067B2 (en) 2006-11-09 2012-04-03 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
GB0700374D0 (en) 2007-01-09 2007-02-14 Oncomethylome Sciences S A NDRG family methylation markers
EP2125659B1 (en) 2007-02-01 2016-01-13 Siemens Healthcare Diagnostics Inc. Silica magnetic particles with a high nucleic acid binding capability
WO2008137772A1 (en) * 2007-05-04 2008-11-13 Dermtech International Diagnosis of melanoma by nucleic acid analysis
US8911937B2 (en) 2007-07-19 2014-12-16 Brainreader Aps Method for detecting methylation status by using methylation-independent primers
US8389215B2 (en) 2007-07-26 2013-03-05 University Of Utah Research Foundation Non-invasive recovery of RNA and analysis of gene expression in skin
WO2009018447A2 (en) 2007-07-31 2009-02-05 New York University Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions
WO2009021141A1 (en) 2007-08-07 2009-02-12 The Johns Hopkins University Comprehensive high throughput arrays for relative methylation
US20090047309A1 (en) 2007-08-13 2009-02-19 Maes Daniel H Cosmetic methods and compositions for repairing human skin
US7965820B2 (en) 2007-08-17 2011-06-21 Brookhaven Science Associates, Llc Fiducial marker for correlating images
KR100999261B1 (ko) 2007-10-09 2010-12-07 (주)아모레퍼시픽 여성호르몬 결핍으로 초래되는 여성 피부의 노화 억제제 스크리닝 방법
EP2053131A1 (en) 2007-10-19 2009-04-29 Ludwig-Maximilians-Universität München Method for determining methylation at deoxycytosine residues
EP2212442A1 (en) 2007-10-26 2010-08-04 Galderma Research & Development Non-invasive method to perform skin inflammatory disease pharmaco-genomic studies and diagnosis method thereof
US20090246768A1 (en) 2008-02-15 2009-10-01 Sawalha Amr H Predicting and Diagnosing Patients With Autoimmune Disease
AU2009221778A1 (en) 2008-03-05 2009-09-11 The Regents Of The University Of California Molecular diagnosis and classification of malignant melanoma
US20110033842A1 (en) 2008-04-04 2011-02-10 Woo Chul Moon Skin Sampling Kit Which Stores Nucleic Acids In Stable Status, Genetic Test Methods By Using The Kit And Their Practical Application
WO2009131733A1 (en) 2008-04-21 2009-10-29 The Trustees Of Columbia University In The City Of New York Gab2 amplification in melanoma
BRPI0913578A2 (pt) 2008-05-14 2017-06-06 Dermtech Int diagnose de melanoma e lentigo solar por análise de ácido nucléico
JP5568807B2 (ja) 2008-06-06 2014-08-13 静岡県 プロテオミクス解析を用いたメラノーママーカーの同定
WO2009155310A1 (en) 2008-06-17 2009-12-23 University Of Rochester Tumor suppression through plexin c1
EP2151505A1 (en) 2008-08-05 2010-02-10 Institut Gustave Roussy Method for determining a predisposition to basal cell carcinoma and for screening treatments thereof
US20100086501A1 (en) 2008-08-28 2010-04-08 Dermtech International Determining Age Ranges of Skin Samples
AU2009298150A1 (en) 2008-10-03 2010-04-08 Dana-Farber Cancer Institute, Inc. Compositions, kits and methods for the diagnosis, prognosis, and monitoring of cancer using GOLPH3
US20100105102A1 (en) 2008-10-22 2010-04-29 Reveal Sciences, Llc Device, method and apparatus for analyzing skin and hair
US20110287034A1 (en) 2008-11-14 2011-11-24 The Brigham And Womens Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
GB2512153B (en) 2008-11-17 2014-11-12 Veracyte Inc Methods and compositions of molecular profiling for disease diagnostics
HU0900117D0 (en) 2009-02-26 2009-04-28 Genetic Immunity Kutatasi Topical or transdermal delivery kit
US20130143747A1 (en) 2011-12-05 2013-06-06 Myriad Genetics, Incorporated Methods of detecting cancer
US20110040571A1 (en) 2009-08-14 2011-02-17 Felicity Warren System and method for providing for teledermatology
WO2011039734A2 (en) 2009-10-02 2011-04-07 Enzo Medico Use of genes involved in anchorage independence for the optimization of diagnosis and treatment of human cancer
US20110091384A1 (en) 2009-10-13 2011-04-21 The Johns Hopkins University Biomarker for identification of melanoma tumor cells
GB0921329D0 (en) 2009-12-04 2010-01-20 Univ Surrey Biomarker
US20130079423A1 (en) 2010-02-24 2013-03-28 Myriad Genetics, Incorporated Diagnostic methods involving loss of heterozygosity
US8741561B2 (en) 2010-03-01 2014-06-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Gene sets for detection of ultraviolet A exposure and methods of use thereof
AU2011242990B2 (en) 2010-04-19 2015-02-12 Biomarker Strategies, Llc. Compositions and methods for prediction of drug sensitivity, resistance, and disease progression
GB201012590D0 (en) 2010-07-27 2010-09-08 Queen Mary & Westfield College Methods for diagnosing cancer
WO2012030840A2 (en) 2010-08-30 2012-03-08 Myriad Genetics, Inc. Gene signatures for cancer diagnosis and prognosis
WO2012031008A2 (en) 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
US20130237445A1 (en) 2010-09-14 2013-09-12 The University Of North Carolina At Chapel Hill Methods and kits for detecting melanoma
AU2011305696A1 (en) 2010-09-20 2013-05-02 Advanced Cell Diagnostics, Inc. Biomarkers for differentiating melanoma from benign nevus in the skin
US20120201750A1 (en) 2010-09-20 2012-08-09 Bungwoo Ryu Serum biomarkers for melanoma metastasis
WO2012115885A1 (en) 2011-02-22 2012-08-30 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers
WO2012125411A1 (en) 2011-03-11 2012-09-20 Metamark Genetics, Inc. Methods of predicting prognosis in cancer
KR20140072014A (ko) 2011-06-16 2014-06-12 카리스 라이프 사이언스 룩셈부르크 홀딩스, 에스.에이.알.엘. 생물지표 조성물 및 방법
WO2013011378A1 (en) 2011-07-15 2013-01-24 Leo Pharma A/S Diagnostic microrna profiling in cutaneous t-cell lymphoma (ctcl)
KR20140067001A (ko) 2011-08-08 2014-06-03 카리스 라이프 사이언스 룩셈부르크 홀딩스, 에스.에이.알.엘. 생물지표 조성물 및 방법
HK1199099A1 (en) 2011-08-31 2015-06-19 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of cancer
EP2758032B1 (en) 2011-09-21 2021-10-27 Shiseido Americas Corporation Compositions and methods for treating conditions of compromised skin barrier function
EP2758536B1 (en) 2011-09-23 2019-02-27 Galderma Research & Development Human keratinocytes ptch1 cell line
US9926604B2 (en) 2011-10-14 2018-03-27 The Regents Of The University Of California Multiplex PCR-based testing of cutaneous squamous cell carcinoma and pseudoepitheliomatous hyperplasia and methods for distinguishing the same
SG11201401202YA (en) 2011-10-19 2014-06-27 Morphosys Ag Antagonists of il17c for the treatment of inflammatory disorders
IN2014CN04935A (enExample) 2011-12-31 2015-09-18 Moni Abraham Kuriakose
EP2845910A4 (en) 2012-05-02 2015-11-25 Mitsubishi Rayon Co PROBE OR PROBE TO EVALUATE THE INFLUENCE OF ULTRAVIOLET RADIATION ON SKIN AND NUCLEIC ACID MICRO ARRAYS
WO2013184905A1 (en) 2012-06-06 2013-12-12 Myriad Genetics, Inc. Hereditary cancer genes
ES2765573T3 (es) 2012-08-13 2020-06-09 Univ Rockefeller Tratamiento y diagnóstico de melanoma
ES3015226T3 (en) 2012-08-16 2025-04-30 Veracyte Sd Inc Prostate cancer prognosis using biomarkers
US9103749B2 (en) 2012-10-11 2015-08-11 Fast Forward Forensics, LLC Biological sample collection apparatus
US20160051493A1 (en) 2012-11-19 2016-02-25 The Trustees Of Columbia University In The City Of New York Methods of treatment of keratinocyte-derived lesions
TWI493169B (zh) 2013-01-18 2015-07-21 Univ Nat Cheng Kung 評估皮膚生理參數濃度及分布之光學系統及其方法
KR101832948B1 (ko) 2013-02-18 2018-02-28 듀크 유니버시티 신경교종 및 종양의 서브세트 내 tert 프로모터 돌연변이
WO2014130507A1 (en) 2013-02-22 2014-08-28 Avery Dennison Corporation Multi-layer optically clear adhesives, foams, transfer tapes, and articles comprising such adhesives
US20140323331A1 (en) 2013-04-26 2014-10-30 Dermtech International Biomarkers for diagnosis and treatment of acne vulgaris
TW201537175A (zh) 2013-06-28 2015-10-01 Chugai Pharmaceutical Co Ltd 預測罹患具皮膚搔癢之疾病的患者對il-31拮抗劑之治療的反應之方法
US20150005184A1 (en) 2013-06-28 2015-01-01 Dermtech International Diagnosis of melanoma by nucleic acid analysis
US20150377751A1 (en) 2013-08-01 2015-12-31 The Procter & Gamble Company Method of collecting and quantifying melanin in skin
FR3011009B1 (fr) 2013-09-25 2016-11-25 Oreal Signature bacterienne de la dermatite atopique et son utilisation dans la prevention et/ou le traitement de cette pathologie
AU2014367369B2 (en) 2013-12-19 2020-03-26 Instytut Biologii Doswiadczalnej Im. M. Nenckiego Polskiej Akademii Nauk A method for detecting an increased risk of developing skin cancer and a use of a genotype variant of the GRHL3 gene
US20220387005A1 (en) 2021-06-04 2022-12-08 Dermtech, Inc. Sample collection system
US20170115291A1 (en) 2014-05-28 2017-04-27 Dana-Farber Cancer Institute, Inc. Activating JAK Kinase Biomarkers Predictive of Anti-Immune Checkpoint Inhibitor Response
WO2015191783A2 (en) 2014-06-10 2015-12-17 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same
US20160024595A1 (en) 2014-07-22 2016-01-28 Dermtech International Characterization of melanoma using a molecular signature
WO2016030287A1 (de) 2014-08-27 2016-03-03 Heraeus Deutschland GmbH & Co. KG Verfahren zur herstellung einer lötverbindung
US10709428B2 (en) 2015-05-01 2020-07-14 Dermtech, Inc. Non-invasive skin collection system
US20180328945A1 (en) 2015-11-10 2018-11-15 Pathway Skin, Inc. Methods and Systems for Improving Skin Condition
US10852307B2 (en) 2015-12-22 2020-12-01 National Jewish Health Methods of detecting and preventing atopic allergic diseases
JP6930992B2 (ja) 2016-02-29 2021-09-01 ファウンデーション・メディシン・インコーポレイテッド 腫瘍変異負荷を評価するための方法及びシステム
WO2017165199A1 (en) 2016-03-25 2017-09-28 The Trustees Of Columbia University In The City Of New York Next-generation biomarkers to detect sun damage and predict skin cancer risk
US20170329929A1 (en) 2016-05-11 2017-11-16 Sensus Healthcare Llc Virtual pathology for dermatology
CN106119242A (zh) 2016-06-24 2016-11-16 毕建红 一种基于自动化工作站的疑难微量法医物证dna提取试剂盒及其方法
EP3481391A4 (en) 2016-07-11 2020-03-11 Lifesci Pharmaceuticals, Inc. THERAPEUTIC INHIBITOR COMPOUNDS
WO2018065384A1 (en) 2016-10-03 2018-04-12 Galderma Research & Development Expression profiles of abc and slc transporters in human and minipig skin, liver and kidney
WO2018087155A1 (en) 2016-11-09 2018-05-17 F. Hoffmann-La Roche Ag Automated tissue dissection instrument and methods of using the same
US11441192B2 (en) 2016-11-15 2022-09-13 Quest Diagnostics Investments Llc Methods for detecting DNA mutations using mitra tip extraction
FR3060755B1 (fr) 2016-12-16 2024-07-12 Oreal Methode de diagnostic d'une peau presentant des signes de secheresse
US11911012B2 (en) 2017-03-03 2024-02-27 Children's Hospital Medical Center Non-invasive methods for skin sample collection and analysis
CA3059425A1 (en) 2017-04-10 2018-10-18 Dermtech, Inc. Non-invasive skin-based detection methods
CA3068437A1 (en) 2017-06-27 2019-01-03 The Regents Of The University Of California Mhc-i genotype restricts the oncogenic mutational landscape
US11976332B2 (en) 2018-02-14 2024-05-07 Dermtech, Inc. Gene classifiers and uses thereof in non-melanoma skin cancers
CA3099275A1 (en) 2018-05-09 2019-11-14 Dermtech, Inc. Novel gene classifiers and uses thereof in autoimmune diseases
BR112020024715A2 (pt) 2018-06-04 2021-03-23 Avon Products. Inc. biomarcadores proteicos para identificar e tratar o envelhecimento da pele e afecções cutâneas
GB201810897D0 (en) 2018-07-03 2018-08-15 Chronomics Ltd Phenotype prediction
GB2576374A (en) 2018-08-17 2020-02-19 Ecole Polytechnique Fed Lausanne Epfl Skin cell analysis
CN109785903A (zh) 2018-12-29 2019-05-21 哈尔滨工业大学(深圳) 一种基因表达数据分类器
AU2020247911A1 (en) 2019-03-26 2021-11-11 Dermtech, Llc Novel gene classifiers and uses thereof in skin cancers
MX2021012206A (es) 2019-04-05 2021-12-10 Dermtech Inc Clasificadores de genes novedosos para su uso en el monitoreo de daño ultravioleta.
AU2021259608A1 (en) 2020-04-22 2022-11-17 Dermtech, Inc. Teledermatology system and methods
AU2021267387A1 (en) 2020-05-08 2022-11-24 Dermtech, Llc Automated sample scanning and segregation system and methods
WO2022115487A1 (en) 2020-11-24 2022-06-02 Dermtech, Inc. Assessment of mutation burden in skin
US20240167102A1 (en) 2021-03-02 2024-05-23 Dermtech, Inc. Predicting therapeutic response
US20240191309A1 (en) 2021-04-13 2024-06-13 Dermtech, Inc. Gene classifiers and uses thereof

Also Published As

Publication number Publication date
AU2009246180B2 (en) 2015-11-05
CN102089444A (zh) 2011-06-08
JP2011520451A (ja) 2011-07-21
US11332795B2 (en) 2022-05-17
US20110160080A1 (en) 2011-06-30
US20210222258A1 (en) 2021-07-22
AU2009246180A1 (en) 2009-11-19
EP2294216A4 (en) 2011-11-23
US20140154684A1 (en) 2014-06-05
BRPI0913578A2 (pt) 2017-06-06
US20210198749A1 (en) 2021-07-01
EP2626437A2 (en) 2013-08-14
CA2724322A1 (en) 2009-11-19
US11753687B2 (en) 2023-09-12
US20210246514A1 (en) 2021-08-12
WO2009140550A3 (en) 2010-02-25
US10407729B2 (en) 2019-09-10
EP2626437A3 (en) 2013-12-11
EP2294216A2 (en) 2011-03-16
US20150361509A1 (en) 2015-12-17
WO2009140550A2 (en) 2009-11-19
WO2009140550A9 (en) 2010-01-07
US9057109B2 (en) 2015-06-16
US20140256584A1 (en) 2014-09-11
US20190367994A1 (en) 2019-12-05

Similar Documents

Publication Publication Date Title
US11753687B2 (en) Diagnosis of melanoma and solar lentigo by nucleic acid analysis
US20080274908A1 (en) Diagnosis of melanoma by nucleic acid analysis
Prueitt et al. Expression of microRNAs and protein‐coding genes associated with perineural invasion in prostate cancer
AU2009285645B2 (en) Determining age ranges of skin samples
US20150005184A1 (en) Diagnosis of melanoma by nucleic acid analysis
US20090192045A1 (en) Molecular staging of stage ii and iii colon cancer and prognosis
WO2014176446A1 (en) Biomarkers for diagnosis and treatment of acne vulgaris
WO2012093821A2 (ko) 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법
US20140100125A1 (en) Methods, Kits and Compositions for Determining Severity and Survival of Heart Failure in a Subject
Hwang et al. Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer
US20150329911A1 (en) Nucleic acid biomarkers for prostate cancer
Class et al. Patent application title: DIAGNOSIS OF MELANOMA AND SOLAR LENTIGO BY NUCLEIC ACID ANALYSIS Inventors: Sherman H. Chang (San Diego, CA, US) Sherman H. Chang (San Diego, CA, US)
KR20260048449A (ko) 만성 b형 간염에 의한 조기 간암 진단을 위한 바이오마커
HK1155781A (en) Method and apparatus for determining a probability of colorectal cancer in a subject

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140513

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-4-4-R10-R11-R127 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER RECORDAL REQUEST OR RESPONSE

Effective date: 20250306

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250423

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 16TH ANNIV.) - STANDARD

Year of fee payment: 16

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250509

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250509

R14 Transfer of ownership recorded

Free format text: ST27 STATUS EVENT CODE: A-4-4-R10-R14-R129 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20251117